METSELEX INC has a total of 16 patent applications. It decreased the IP activity by 100.0%. Its first patent ever was published in 2012. It filed its patents most often in United States, WIPO (World Intellectual Property Organization) and China. Its main competitors in its focus markets pharmaceuticals, organic fine chemistry and biotechnology are SOFT DRUGS INC, SAGE THERAPEUTICS INC and PURDUE PHARMA LTD.
# | Country | Total Patents | |
---|---|---|---|
#1 | United States | 9 | |
#2 | WIPO (World Intellectual Property Organization) | 6 | |
#3 | China | 1 |
# | Industry | |
---|---|---|
#1 | Pharmaceuticals | |
#2 | Organic fine chemistry | |
#3 | Biotechnology | |
#4 | Measurement | |
#5 | Medical technology |
# | Technology | |
---|---|---|
#1 | Therapeutic chemical compounds | |
#2 | Medical preparations | |
#3 | Steroids | |
#4 | Diagnosis and surgery | |
#5 | Peptides | |
#6 | Microorganisms | |
#7 | Analysing materials |
# | Name | Total Patents |
---|---|---|
#1 | Steer Clifford | 9 |
#2 | Munshi Cyrus B | 8 |
#3 | Rodrigues Cecilia M P | 6 |
#4 | Low Walter | 6 |
#5 | Dias Lucas De Oliveira Susana | 6 |
#6 | Finch Michael D | 5 |
#7 | Finch Michael | 4 |
#8 | Rodrigues Cecilia | 3 |
#9 | Leong Mai Lan | 2 |
#10 | Gupta Sandeep | 2 |
Publication | Filing date | Title |
---|---|---|
US2021122780A1 | Compositions for the prevention and treatment of parkinson's disease | |
US2018044373A1 | Fluorinated and alkylated bile acids | |
WO2015061421A1 | Deuterated bile acids | |
US2014323748A1 | Water-soluble ursodeoxycholic acid prodrugs | |
WO2014160877A1 | Prevention and treatment of kidney damage by bile acids | |
WO2013142490A2 | Tauroursodeoxycholic acid attenuates or abolishes formation and deposition of amyloid-b peptide | |
WO2013067096A2 | Prevention or attenuation of neuropathic pain and kidney injury by tauroursodeoxycholic acid |